{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:32:33Z","timestamp":1791772353639,"version":"4.3.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T00:00:00Z","timestamp":1613433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.beem.2021.101508","type":"journal-article","created":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:36:49Z","timestamp":1613608609000},"page":"101508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Gut microbiota and metabolic aspects of cancer cachexia"],"prefix":"10.1016","volume":"35","author":[{"given":"Janine","family":"Ziemons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein L.","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Olde","family":"Damink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander S.","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2021.101508_bib1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.beem.2021.101508_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2012.06.011","article-title":"Cancer cachexia: mediators, signaling, and metabolic pathways","volume":"16","author":"Fearon","year":"2012","journal-title":"Cell Metabol"},{"key":"10.1016\/j.beem.2021.101508_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.601329","article-title":"Nutritional interventions in cancer cachexia: evidence and perspectives from experimental models","volume":"7","author":"van de Worp","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.beem.2021.101508_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.3","article-title":"Understanding cachexia as a cancer metabolism syndrome","volume":"5","author":"Porporato","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.beem.2021.101508_bib5","first-page":"250","article-title":"Two faces of drug therapy in cancer: drug-related lean tissue loss and its adverse consequences to survival and toxicity","volume":"14","author":"Prado","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.beem.2021.101508_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","article-title":"Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014","volume":"5","author":"von Haehling","year":"2014","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.beem.2021.101508_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.beem.2021.101508_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","article-title":"Understanding the mechanisms and treatment options in cancer cachexia","volume":"10","author":"Fearon","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.beem.2021.101508_bib9","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/hpb.12373","article-title":"Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?","volume":"17","author":"Lodewick","year":"2015","journal-title":"HPB : Off J Int Hepato Pancreato Biliary Assoc"},{"key":"10.1016\/j.beem.2021.101508_bib10","article-title":"The immunological regulation of cancer cachexia and its therapeutic implications","volume":"5","author":"Miller","year":"2019","journal-title":"J\u00a0Cancer Metastasis Treat"},{"key":"10.1016\/j.beem.2021.101508_bib11","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/ismej.2015.209","article-title":"Synbiotic approach restores intestinal homeostasis and prolongs survival in leukaemic mice with cachexia","volume":"10","author":"Bindels","year":"2016","journal-title":"ISME J"},{"key":"10.1016\/j.beem.2021.101508_bib12","doi-asserted-by":"crossref","first-page":"18224","DOI":"10.18632\/oncotarget.24804","article-title":"Increased gut permeability in cancer cachexia: mechanisms and clinical relevance","volume":"9","author":"Bindels","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.beem.2021.101508_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037971","article-title":"Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model","volume":"7","author":"Bindels","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.beem.2021.101508_bib14","doi-asserted-by":"crossref","first-page":"12321","DOI":"10.1038\/s41598-018-30569-5","article-title":"Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction","volume":"8","author":"P\u00f6tgens","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2021.101508_bib15","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3390\/cancers11111799","article-title":"Blocking activin receptor ligands is not sufficient to rescue cancer-associated gut microbiota\u2014a role for gut microbial flagellin in colorectal cancer and cachexia?","volume":"11","author":"Pekkala","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.beem.2021.101508_bib16","first-page":"364","article-title":"Fungal dysbiosis correlates with the development of tumor-induced cachexia in mice","volume":"6","author":"Jabes","year":"2020","journal-title":"J\u00a0Fungi"},{"key":"10.1016\/j.beem.2021.101508_bib17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature18846","article-title":"Diet-microbiota interactions as moderators of human metabolism","volume":"535","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.beem.2021.101508_bib18","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/bjc.2016.3","article-title":"Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia","volume":"114","author":"Penafuerte","year":"2016","journal-title":"Br J Canc"},{"key":"10.1016\/j.beem.2021.101508_bib19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ni.3780","article-title":"Regulation of inflammation by microbiota interactions with the host","volume":"18","author":"Blander","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.beem.2021.101508_bib20","doi-asserted-by":"crossref","first-page":"E607","DOI":"10.1002\/oby.20466","article-title":"Human intestinal microbiota composition is associated with local and systemic inflammation in obesity","volume":"21","author":"Verdam","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.beem.2021.101508_bib21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2012.10.007","article-title":"Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications","volume":"69","author":"Natividad","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.beem.2021.101508_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.beem.2021.101508_bib23","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.bbadis.2011.08.010","article-title":"Gut barrier dysfunction in the Apc(Min\/+) mouse model of colon cancer cachexia","volume":"1812","author":"Puppa","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.beem.2021.101508_bib24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1089\/jir.2013.0020","article-title":"The altered tight junctions: an important gateway of bacterial translocation in cachexia patients with advanced gastric cancer","volume":"34","author":"Jiang","year":"2014","journal-title":"J\u00a0Interferon Cytokine Res"},{"key":"10.1016\/j.beem.2021.101508_bib25","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/nutrit\/nuw067","article-title":"Role of short-chain fatty acids in colonic inflammation, carcinogenesis, and mucosal protection and healing","volume":"75","author":"van der Beek","year":"2017","journal-title":"Nutr Rev"},{"key":"10.1016\/j.beem.2021.101508_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101499","article-title":"Impact of diet-modulated butyrate production on intestinal barrier function and inflammation","volume":"10","author":"Bach Knudsen","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.beem.2021.101508_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/S0007114508888733","article-title":"Physiological concentrations of short-chain fatty acids immediately suppress colonic epithelial permeability","volume":"100","author":"Suzuki","year":"2008","journal-title":"Br J Nutr"},{"key":"10.1016\/j.beem.2021.101508_bib28","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1136\/gutjnl-2018-316161","article-title":"Distal versus proximal intestinal short-chain fatty acid release in man","volume":"68","author":"Neis","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.beem.2021.101508_bib29","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1038\/cti.2016.17","article-title":"Regulation of immune cell function by short-chain fatty acids","volume":"5","author":"Corr\u00eaa-Oliveira","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.beem.2021.101508_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gut.47.3.397","article-title":"Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn\u2019s disease","volume":"47","author":"Segain","year":"2000","journal-title":"Gut"},{"key":"10.1016\/j.beem.2021.101508_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.intimp.2017.07.023","article-title":"Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner","volume":"51","author":"Lee","year":"2017","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.beem.2021.101508_bib32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1126\/science.aac6468","article-title":"Disease tolerance mediated by microbiome E. coli involves inflammasome and IGF-1 signaling","volume":"350","author":"Schieber","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.beem.2021.101508_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131009","article-title":"Non digestible oligosaccharides modulate the gut microbiota to control the development of leukemia and associated cachexia in mice","volume":"10","author":"Bindels","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.beem.2021.101508_bib34","doi-asserted-by":"crossref","first-page":"E158","DOI":"10.1152\/ajpendo.00521.2018","article-title":"Gut bacteria are critical for optimal muscle function: a potential link with glucose homeostasis","volume":"317","author":"Nay","year":"2019","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.beem.2021.101508_bib35","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1096\/fj.201801209R","article-title":"Gut microbiome catabolites as novel modulators of muscle cell glucose metabolism","volume":"33","author":"Houghton","year":"2019","journal-title":"Faseb J"},{"key":"10.1016\/j.beem.2021.101508_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13539-011-0051-5","article-title":"The role of insulin resistance in the development of muscle wasting during cancer cachexia","volume":"3","author":"Honors","year":"2012","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.beem.2021.101508_bib37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/nu8040205","article-title":"Lactobacillus plantarum TWK10 supplementation improves exercise performance and increases muscle mass in mice","volume":"8","author":"Chen","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/j.beem.2021.101508_bib38","doi-asserted-by":"crossref","first-page":"31786","DOI":"10.1038\/srep31786","article-title":"Gut microbiota can transfer fiber characteristics and lipid metabolic profiles of skeletal muscle from pigs to germ-free mice","volume":"6","author":"Yan","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.beem.2021.101508_bib39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1073\/pnas.0605374104","article-title":"Mechanisms underlying the resistance to diet-induced obesity in germ-free mice","volume":"104","author":"B\u00e4ckhed","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.beem.2021.101508_bib40","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.3390\/nu7042930","article-title":"The role of microbial amino acid metabolism in host metabolism","volume":"7","author":"Neis","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.beem.2021.101508_bib41","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.molmet.2016.06.002","article-title":"Causality of small and large intestinal microbiota in weight regulation and insulin resistance","volume":"5","author":"Scheithauer","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.beem.2021.101508_bib42","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/nature05414","article-title":"An obesity-associated gut microbiome with increased capacity for energy harvest","volume":"444","author":"Turnbaugh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.beem.2021.101508_bib43","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrendo.2015.128","article-title":"Short-chain fatty acids in control of body weight and insulin sensitivity","volume":"11","author":"Canfora","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2021.101508_bib44","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/JOE-15-0469","article-title":"The role of bile acids in metabolic regulation","volume":"228","author":"Vitek","year":"2016","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.beem.2021.101508_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179739","article-title":"Microbiota in anorexia nervosa: the triangle between bacterial species, metabolites and psychological tests","volume":"12","author":"Borgo","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.beem.2021.101508_bib46","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.beem.2021.101508_bib47","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/nrgastro.2017.75","article-title":"Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics","volume":"14","author":"Gibson","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.beem.2021.101508_bib48","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41575-020-0344-2","article-title":"The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics","volume":"17","author":"Swanson","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.beem.2021.101508_bib49","doi-asserted-by":"crossref","first-page":"11803","DOI":"10.18632\/oncotarget.7730","article-title":"Beneficial bacteria inhibit cachexia","volume":"7","author":"Varian","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.beem.2021.101508_bib50","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.2276","article-title":"Probiotic Bacillus coagulans GBI-30, 6086 reduces exercise-induced muscle damage and increases recovery","volume":"4","author":"J\u00e4ger","year":"2016","journal-title":"PeerJ"},{"key":"10.1016\/j.beem.2021.101508_bib51","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.3390\/nu12072029","article-title":"The effects of prebiotic supplementation with OMNi-LOGiC\u00ae FIBRE on fecal microbiome, fecal volatile organic compounds, and gut permeability in murine neuroblastoma-induced tumor-associated cachexia","volume":"12","author":"Oberm\u00fcller","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.beem.2021.101508_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","article-title":"The microbiome, cancer, and cancer therapy","volume":"25","author":"Helmink","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.beem.2021.101508_bib53","series-title":"MS-20 on gut microbiota and risk\/severity of cachexia in pancreatic cancer patients - ClinicalTrials.gov","year":"2021"},{"key":"10.1016\/j.beem.2021.101508_bib54","series-title":"Investigation of the gut microbiota in patients with acute myeloid leukemia - ClinicalTrials.gov","year":"2021"},{"key":"10.1016\/j.beem.2021.101508_bib55","series-title":"Abstracts of the 11th international conference on cachexia, sarcopenia and muscle wasting, Maastricht, The Netherlands, 7\u20139 december 2018. Abstract 2-25","first-page":"1121","author":"Ubachs","year":"2018"},{"key":"10.1016\/j.beem.2021.101508_bib56","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00384-017-2819-3","article-title":"Study protocol on the role of intestinal microbiota in colorectal cancer treatment: a pathway to personalized medicine 2.0","volume":"32","author":"Aarnoutse","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/j.beem.2021.101508_bib57","article-title":"Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer","volume":"27","author":"Kim","year":"2018","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.beem.2021.101508_bib58","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.beem.2021.101508_bib59","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ccell.2018.03.004","article-title":"The intestinal microbiota in colorectal cancer","volume":"33","author":"Tilg","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.beem.2021.101508_bib60","doi-asserted-by":"crossref","first-page":"530","DOI":"10.17235\/reed.2016.4261\/2016","article-title":"Gastric microbiota and carcinogenesis: the role of non-Helicobacter pylori bacteria - a systematic review","volume":"108","author":"Dias-J\u00e1come","year":"2016","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.beem.2021.101508_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20174145","article-title":"The clinical link between human intestinal microbiota and systemic cancer therapy","volume":"20","author":"Aarnoutse","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.beem.2021.101508_bib62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","article-title":"Diversity, stability and resilience of the human gut microbiota","volume":"489","author":"Lozupone","year":"2012","journal-title":"Nature"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X21000257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:57:38Z","timestamp":1761497858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X21000257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1521690X21000257"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2021.101508","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota and metabolic aspects of cancer cachexia","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2021.101508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101508"}}